The targets of 87 therapeutic targets for the treatment of GC include TP53, ERS1, EGFR, FOS, MAPK8, RELA, CCND1, CASP8, IL-6, CASP3, HIF1A, MDM2, and BCL2. This evidence concerns the gene FOS and gastric cancer.